indications for glp 1 agonists GI Adverse Effects of Glucagon-Like Peptide-1 Receptor Nutritional priorities to support GLP-1
Description
10.1186/s10194-023-01631-z
This discovery led to the development of exenatide, which in 2005 became the first GLP-1 receptor agonist approved by the FDA for the treatment of type 2 diabetes (T2DM)
The therapeutic scope of GLP-1 receptor agonists extends beyond diabetes to multiple other conditions
Over the last couple of decades, Pratley says, the scientific research community has learned that incretin hormones, including GLP-1, GIP, and others, are important regulators of metabolism with impacts on glycemia, lipids, and body weight
Dual agonist: GLP-1 plus GIP: Tirzapeptide is a combination of GLP-1 RA and a GIP agonist that is FDA-approved for weight loss
The exception is semaglutide which seems to have a better safety profile than the other GLP-1s available
